MARKET

NVO

NVO

Novo-Nordisk A/S
NYSE
65.77
+0.92
+1.42%
After Hours: 65.98 +0.21 +0.32% 19:59 05/09 EDT
OPEN
67.00
PREV CLOSE
64.85
HIGH
67.44
LOW
65.59
VOLUME
13.07M
TURNOVER
--
52 WEEK HIGH
145.16
52 WEEK LOW
57.00
MARKET CAP
221.38B
P/E (TTM)
19.32
1D
5D
1M
3M
1Y
5Y
1D
NVO Quantitative Stock Analysis - Warren Buffett
NASDAQ · 1d ago
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs 
Reuters · 1d ago
Pharma Worries Shift to Prices From Trade. Trump's Next Plan Could Sink Stocks.
Barron‘s · 1d ago
After Hours Most Active for May 9, 2025 : BB, NVDA, HPE, AAPL, UBER, BAC, GOOGL, GRAB, INTC, NVO, SHO, TSLA
NASDAQ · 1d ago
Deal Dispatch: Nestlé, Coinbase, OpenAI Lead Diverse M&A Lineup As WeightWatchers Goes Bankrupt
Benzinga · 1d ago
Optimistic With An Asterisk
Seeking Alpha · 1d ago
Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025
NASDAQ · 1d ago
Novo Nordisk: It's Not Been This Cheap For Many Years
Seeking Alpha · 2d ago
More
About NVO
More
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Recently
Symbol
Price
%Change

Webull offers Novo Nordisk A/S (ADR) stock information, including NYSE: NVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVO stock methods without spending real money on the virtual paper trading platform.